正元胶囊联合程序性死亡受体1抗体治疗晚期肺癌的临床观察(4)
[8]Ksienski D，Wai E S，Croteau N，et al.Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events：A Retrospective Multicenter Analysis[J].Clin Lung Cancer ......
您现在查看是摘要页，全文长 2180 字符。